Clinical trial
Prospective, Randomized, Double-blind, Placebo-controlled Clinical Study of Yuekang Huoxin Pill (Concentrated Pill) Intervening in the Prognosis of Patients With Coronary Heart Disease After Drug-Coated Balloon Implantation With Qi Deficiency and Blood Stasis Syndrome
NCT05489016 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Randomized, Double-blind, Placebo-controlled Clinical Study of Yuekang Huoxin Pill (Concentrated Pill) Intervening in the Prognosis of Patients With Coronary Heart Disease After Drug-Coated Balloon Implantation With Qi Deficiency and Blood Stasis Syndrome
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 5, 2022
- Completion date
- July 13, 2025
- Enrollment
- 440 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
coronary heart disease, medicine, chinese traditional